Author:
Suárez-García Susana,Caimari Antoni,del Bas Josep Maria,Suárez Manuel,Arola Lluís
Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Joffres, M., Shields, M., Tremblay, M. S. & Gorber, S. C. Dyslipidemia prevalence, treatment, control, and awareness in the Canadian Health Measures Survey. Can. J. Public Heal. 104, e252–7 (2013).
2. Steinhagen-Thiessen, E. et al. Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc. Diabetol. 7, 31 (2008).
3. Joshi, S. R. et al. Prevalence of dyslipidemia in urban and rural India: The ICMR–INDIAB Study. PLoS One 9, e96808 (2014).
4. Jellinger, P. et al. American Association of Clinical Endocrinologists’ Guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr. Pract. 18, 1–78 (2012).
5. Mahmood, Z., Ahmed, S., Sualeh, M. & SBZ, M. Hyperlipidemia development and consequences. Med. channel 15, 14–17 (2009).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献